ArticleCancers2024

Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer.

Tetsuya Kokabu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.